NEW YORK, June 26, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced it has ...
Mesoblast (NASDAQ:MESO) added ~13% in the morning hours on Tuesday after the Australian biotech said that the FDA agreed with the company regarding key components of a marketing application (BLA) ...
BrainAlignNet, AutoCellLabeler, and CellDiscoveryNet—to automatically track and identify neurons in moving worms and jellyfish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results